PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesotheliomaKrisztián Homicskó, Rolf A. Stahel, P.M. Fisher et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 14
B-Cell Infiltration is Associated with Survival Outcomes Following Programmed Cell Death Protein 1 Inhibition in Head and Neck Squamous Cell CarcinomaNiki Gavrielatou, Amanda Psyrri, Ekaterina Fortis et al.|SSRN Electronic Journal|2023Cited by 3
Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142).Amanda Psyrri, Periklis Foukas, Niki Gavrielatou et al.|Journal of Clinical Oncology|2019Cited by 2
P-78 Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142)Niki Gavrielatou, Amanda Psyrri, Ekaterina Fortis et al.|Oral Oncology|2021Cited by 0
Abstract 1256: B-cell infiltration is associated with survival outcomes in nivolumab-treated head and neck squamous cell carcinoma (HNSCC): NCT 03652142Niki Gavrielatou, Amanda Psyrri, Ekaterina Fortis et al.|Cancer Research|2022Cited by 0